The biopharmaceutical sector might look to one of the already published submissions to Treasury's review for insights on how its own tax strategies might be scrutinised.
Submission to Treasury review calls for an end to 'favourable tax treatment'
October 7, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
If the demand is to pay for reform, are these reforms really worth paying for?
May 18, 2026 - - Latest News -
Government sidesteps committee call on CGMs, insulin pumps and GLP‑1 access
May 18, 2026 - - Latest News -
Budget papers signal the work that has already been done on reform proposals
May 18, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast -
New Zealand still falling behind on access to modern medicines
May 15, 2026 - - Latest News -
AusBiotech welcomes Budget's creation of new National Resilience and Science Council
May 15, 2026 - - Latest News -
Minister fired the starting gun in March, he flung the door open in Budget week
May 14, 2026 - - Latest News
